None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adults from 20 to 80 years 2) ASA physical status I and II 3) Patients who voluntarily agreed in writing to participate in the clinical trial 4) Patients planed to undergo laparoscopic cholecystectomy with regular schedule
Exclusion criteria
Exclusion criteria: 1) side effects to local anesthetics or steroids 2) Those who are taboo of neuroprotection such as blood clotting disorder, infection, etc. 3) uncontrolled medical or psychological problem 4) patient does not agree to participate in the study 5) Patients with spinal or thoracic deformities 6) Patients who are pregnant or breastfeeding 7) Patients with pre-operative PTGBD or ENBD 8) Patients who underwent extensive resection during surgery and are expected to have visceral pain too high 9) Patients receiving single port laparoscopic cholecystectomy (including using a robot) 10) Patients with severe intraabdominal adhesion (parkland grade 3 or higher) 11) Patients with a history of intraoperative abdominal surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the difference of postoperative opioid consumption between two groups during 24 hours postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity, location at 0, 1/2, 1, 2, 6, 9, 18, 24 hours after end of surgery;post operative Nausea, vomiting, dizziness, pruritus and hematoma at 0, 1/2, 1, 2, 6, 9, 18, 24 hours after end of surgery;paresthesia or hypoesthesia on block site | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center